Active	Status	Sponsor type	Region	Phase	Filter
20 Active 4 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Song, Xianmin
NCT03798509: Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia	Recruiting	1	18	RoW	Human CD19 targeted T Cells Injection	Hrain Biotechnology Co., Ltd., Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	CD19-positive, Acute Lymphoblastic Leukemia	01/22	01/24